Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease
- Badran H. , et al.
2. The Association of Fibrosis-4 (FIB 4) index with Chronic Kidney Disease Among Type 2 Diabetes Mellitus Patients with Concomitant Non-Alcoholic Fatty Liver Disease: A Single Center Cross-sectional Study
- Pescador A.O. , et al.
3. Platelet Proteomics: A Glimpse Into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis
- Minciuna I. , et al.
4. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH
- Martínez-Arenas L. , et al.
5. The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy
- Wei H. , et al.
6. Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
- de Abreu J.D.M.F. , et al.
7. Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease
- Ferraz-Amaro I. , et al.
8. Alleviating Effect of Akkermansia muciniphila ONE on Hypercholesterolemia in Mice
- Li Y. , et al.
9. Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients
- Ding Y. , et al.
10. Comparison of Fibrosis-4 with FibroScan for Liver Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease Patients: A Cross-sectional Study
- Kakar F. , et al.
11. Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes
- Bódis K. , et al.
12. Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis
- Le M.H. , et al.
13. FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning
- Ding Y. , et al.
14. Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection
- Sefa Sayar M. , et al.
16. Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
- Feng J. , et al.
17. Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
- Al Nadaf L. , et al.
18. Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
- Trifan A. , et al.
20. Clodronate-nintedanib-loaded exosome-liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity
- Ji K. , et al.
21. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
- Amernia B. , et al.
22. High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes
- Saito H. , et al.
23. Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats
- Xiong Y. , et al.
24. Beneficial effects of tamarind trypsin inhibitor in chitosan–whey protein nanoparticles on hepatic injury induced high glycemic index diet: A preclinical study
- Aguiar A.J.F.C. , et al.
25. Non-invasive methods in diagnosis of nonalcoholic fatty liver disease
- Hemida K. , et al.